This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Jim Cramer / Mad Money

Cramer Columns

Morgan Stanley Survives Restructuring (Action Alerts PLUS $)

Company earns continued faith in its business model.

04/20/15 - 04:12 PM EDT

Facebook Forecast: What's Not to Like? (Action Alerts PLUS $)

Social-media giant to report earnings Wednesday.

04/20/15 - 11:54 AM EDT

Merck Should Trade Much Higher (Action Alerts PLUS $)

Sunday's tests support our above-consensus projections.

04/20/15 - 11:11 AM EDT

Target's Lilly Pulitzer Launch a Big Hit (Action Alerts PLUS $)

Living up to the hype, the launch represents a compelling growth driver for the near- to medium-term.

04/20/15 - 10:49 AM EDT

Morgan Stanley's Results Are Exciting (Action Alerts PLUS $)

EPS beat forecasts and trading revenues were stronger.

04/20/15 - 09:45 AM EDT
Time to Accumulate; Google and Europe: Jim Cramer's Best Blogs

Time to Accumulate; Google and Europe: Jim Cramer's Best Blogs

Catch up on Jim Cramer's thinking over the last week about the vulnerable market and the Google antimonopoly case in Europe.

04/18/15 - 01:33 PM EDT

Jim Cramer Explains Why Actavis Is the Healthcare Name to Own

Jim Cramer and Action Alerts PLUS Research Director Jack Mohr discuss why Actavis is severely undervalued and an extremely compelling healthcare investment at these levels.

04/18/15 - 09:00 AM EDT
View All
TheStreet Picks
View All

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Markets

DOW 18,034.93 +208.63 1.17%
S&P 500 2,100.40 +19.22 0.92%
NASDAQ 4,994.6020 +62.7870 1.27%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs